



ECR/ESR takes no responsibility for the content of the Satellite Symposia,
and the opinions expressed therein do not necessarily reflect those of ECR/ESR.
Insights Imaging
DOI 10.1007/s13244-01 -00 -1 80 9
Satellite Symposia
S328 DA B C E F G H
Thursday, March 3
12:30 - 13:30 Room F2 
organised by Siemens
SY 1 
Breast care goes 3D 
Moderator: 
D. Uhlenbrock; Dortmund/DE 
D-01	  
Introduction 
D. Uhlenbrock; Dortmund/DE 
D-02	  
Automated 3D US breast volume scanning 
M. Rutten; ‘s-Hertogenbosch/NL 
Eliminating subjectivity and operator-dependent bias from ultrasound, automated 
breast volume scanning (ABVS), or 3D ultrasound (US), opens the door to new 
applications in mammary diagnostics and beyond. 3D US technique and scan 
methods as well as the post-processing, reviewing and analysing of the 3D breast 
US data sets are explained and illustrated. Our preliminary experience with clini-
cal ABVS applications will be shown and the advantages, limitations and future 
aspects of ABVS will be discussed. 
D-03	  
Digital 3D breast tomosynthesis and its emerging role in breast cancer 
diagnosis 
J. Barkhausen; Lübeck/DE 
Breast cancer is the most common malignant tumour in women and early detec-
tion is most crucial for outcome and survival. Mammography is the most important 
imaging technique for tumour screening and characterisation of focal lesions. 
However, using plain film techniques the three-dimensional object is reduced to 
a two-dimensional image, and therefore small lesion may be undetectable due 
to superimposed glandular tissue. Recently, digital breast tomosynthesis (DBT) 
emerged as a new imaging modality to overcome this limitation. 25 low-dose mam-
mographic projections using a standard mammography system are performed over 
a limited angle of 50 degree. Based on these images a stack of cross-sectional 
images covering the entire breast is reconstructed with an interslice distance of 
1 mm. The glandular dose of a tomosynthesis scan is comparable to a standard 
mammography in two projections. Due to the lack of superimposed tissue tomo-
synthesis images significantly improve the visualisation of small focal lesions. 
Therefore, tomosynthesis is especially helpful in young women with mammographic 
dense breast tissue and in patients with fibrocystic breast disease, whereas the 
additional information is limited in fatty breast tissue. Furthermore, tomosynthesis 
allows better evaluation of focal lesions compared to conventional mammography. 
The detailed analysis of the lesions’ border helps differentiating between summa-
tion artifacts, benign lesions and carcinomas. In conclusion, tomosynthesis will 
not replace conventional mammography in the near future, but provides clinically 
important additional information in difficult cases. Additionally, tomosynthesis has 
the potential to become the imaging modality of first choice in selected patients, 
e.g. with dense breast tissue. 
Learning Objectives:
1. To understand the technical principles of tomosynthesis.
2. To learn how tomosynthesis compares to conventional mammography.
3. To discuss which patients may benefit from tomosynthesis.
D-04	  
More than MR-mammography 
W.A. Kaiser; Jena/DE 
In its third decade of clinical evaluation MRM is backed up by high level of evidence 
in terms of high sensitivity, exact preoperative staging and accurate differential 
diagnosis. This is achieved applying standardised protocols including imaging 
parameters, contrast agent application, reading procedures and reporting. Reliable 
reading and reporting is based on a standardised assessment of morphologic and 
dynamic enhancement criteria. Thus, sensitive and specific diagnosis is reached in 
short time. Prerequisite for this is an optimised imaging protocol. Based on more 
than 25 years of experience, we have developed a robust and fast imaging protocol 
including dynamic T1w and T2w sequences with an overall acquisition time of about 
12 minutes. Modern MRI systems with multichannel capability enable a combination 
of several surface coils. Thus, it is possible to increase the field of view beyond the 
breast. The reasons for doing so are obvious: while exact preoperative T-staging 
is achieved using breast MRI, conventional lymph node and distant metastasis 
staging include additional examinations like bone scintigraphy, ultrasound, x-ray or 
CT. However, multichannel-multicoil technology allows for a local, locoregional and 
distant staging in one examination. Investing 2-3 minutes additional magnet time 
enables imaging of thorax and abdomen including the vertebral bodies, resulting 
in accurate locoregional and distant staging, according to our initial experience. 
The implications of such an approach are a faster and more cost-effective patient 
management using modern MRI. 
Panel discussion 
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Friday, March 4
12:30 - 13:30 Room C 
organised by GE Healthcare
SY 2 
Widening clinical capabilities in MRI: 
latest advances 
D-05	  
Contributions to patient centric MR 
J. Coumans; Waukesha, WI/US 
MR exams have been undergoing serious changes in the past decades. Reimburse-
ment pressures call for ever shorter exam ties, with ever-more problem solving 
diagnostic sequences. Procedure growth in pediatric and geriatric populations, 
and the quest for open bore MR systems to appease feelings of claustrophobia 
require new approaches in MR system design. The lecture will highlight a number 
of initiatives by GE in the above areas. 
D-06	  
New 1.5T MR technology in clinical practice 
B. Wirth; Lons-le-Saunier/FR 
The lecture aims at demonstrating the clinical value of a new 1.5T wide-bore 
whole body MR system equipped with the latest MRI pulse sequences and coils 
in the diagnostic of neurological, abdominal, pelvic, and musculoskeletal diseases. 
Special emphasis will be placed on the use of novel techniques such as contrast 
injected volumetric dynamic acquisitions in combination with fat/water separation 
methods in breast and liver oncology indications, NCE-MRA for the renal arteries, 
and motion-insensitive pulse sequences in abdomen and joints. 
D-07	  
In search for molecular imaging: the tri-modality imaging approach 
G.K. von Schulthess; Zurich/CH 
12:30 - 13:30 Room D1 
organised by Bayer Schering Pharma
SY 3 
Advances in contrast enhanced MRI: efficacy, safety 
and applications 
Moderator: 
M. Law; Los Angeles, CA/US
Programme not available by date of print 
12:30 - 13:30 Room E1 
organised by Philips Healthcare
SY 4 
Programme not available by date of print 
12:30 - 13:30 Room G/H 
organised by SuperSonic Imagine
SY 5 
Aixploring the breakthroughs against cancer and 
fibrosis 
Programme not available by date of print 
12:30 - 13:30 Room I/K 
organised by Philips Healthcare
SY 6 
Programme not available by date of print 
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Saturday, March 5
10:30 - 12:00 Room I/K 
organised by Bracco
SY 7 
Programme not available by date of print 
12:30 - 13:45 Room B 
jointly organised by Siemens and Bayer Schering Pharma
SY 8 
Synergies in CT: for better patient care 
Moderator: 
J.E. Wildberger; Maastricht/NL 
D-08	  
Contrast induced nephropathy: does it matter for CT applications 
U.J. Schoepf; Charleston, SC/US 
D-09	  
CT dose optimisation in paediatrics 
M. Siegel; St. Louis, MO/US 
D-10	  
Optimising contrast media application for modern imaging 
A.H. Mahnken; Aachen/DE 
D-11	  
Second generation iterative reconstruction: initial results 
M. Lell; Erlangen/DE 
12:30 - 13:30 Room C 
organised by GE Healthcare
SY 9 
X-ray advanced applications: clinical progress and 
benefits in routine practice 
Moderator: 
L. Katz; Buc/FR 
D-12	  
Imaging metal implants: benefits of digital radiography advanced 
applications 
A. Blum; Nancy/FR 
Flat panel digital radiography (DR) presents significant advantages over CR (high 
DQE, dose reduction, improved workflow and productivity, better workplace ergo-
nomics). This technique allows also new application tools, such as dual-energy and 
tomosynthesis, which increase the diagnostic value of radiography in musculosk-
eletal disorders. Dual Energy techniques produce a high-peak-kilovoltage (kVp) 
image and a low-peak-kVp image with a less than 200-msec temporal separation. 
Post-processing of these two images results in the following images: a standard 
image (high kVp), a subtracted soft-tissues image that removes bone contrast from 
the underlying soft tissue, and a calcium image that displays bone structure. This 
technique also allows the differentiation between Titanium from steel or Chrome/
cobalt alloy and of these metals from iodine or gadolinium mixtures. Therefore 
dual-energy arthrography is a promising tool for the evaluation of painful prosthe-
sis. Digital x-ray tomosynthesis is a very low dose technique for producing slice 
images. The dose reduction is about 1/50 compared to CT-scan and its accuracy 
is superior to plain films in the diagnostic of subtle fractures. Metal artifacts do not 
affect it and the bone-metal interface can be well evaluated. The routine use of 
these techniques may drive significant cost savings in the imaging department. 
D-13	  
Digital breast tomosynthesis: clinical performance and vision 
G. Gennaro; Padua/IT 
Method: The clinical trial (approved by the competent authorities) enrolled 250 consenting 
women with at least one doubtful or suspicious breast lesion discovered by mammography 
and/or ultrasound. Patients underwent bilateral digital mammography in two views (cranio-
caudal, CC, and medio-lateral oblique, MLO) and tomosynthesis in one-view (MLO). Truth 
was established by histology or citology and/or follow-up, according to the standard of 
care. A multi-reader study was conducted retrospectively and involved six independent 
radiologists. The study was performed in two phases, split in time to minimize bias: Phase 
1: Patient images were organized in separate reading sessions, each including both 
FFDM and DBT of different breasts. The readers were asked to localize up to three find-
ings per breast and rate each of them using the BIRADS classification. Phase 2: Reading 
sessions were designed using similar criteria as for Phase 1 with the difference that after 
DBT evaluation, FFDM CC-view was added and evaluation refined using both modali-
ties. The objective was to quantify the potential added value of FFDM CC to DBT MLO. 
Per-breast and per-lesion analyses were performed on the datasets. Per-breast analysis 
compared mean areas ROC curves (AUCs). Per-lesion analysis took into account multiple 
lesions per breast and addressed the overall (benign and malignant) lesion detection rate. 
Results: Phase 1 demonstrated non-inferiority of DBT (MLO) versus FFDM (CC+MLO), 
within 5% non-inferiority margin (AUC(DBT)=0.851; AUC(FFDM)=0.836; AUC differ-
ence=0.014, p=0.645; -95% CL =-0.049). No significant differences were found in sensitivity 
and specificity. Overall lesion detection rate was significantly improved by tomosynthesis 
(69% DBT vs. 65% FFDM, p=0.008), especially in dense breasts. Phase 2 confirmed the 
result regarding non-inferiority. Specificity was significantly higher with DBT compared 
to FFDM (87% vs. 83%, p=0.025). The adjunction of FFDM(CC) increased sensitiv-
ity of DBT alone significantly, allowing detection of 2.1 additional cancers, on average. 
Conclusions: Clinical performance of digital breast tomosynthesis (MLO) and mam-
mography (CC+MLO) are not statistically different. Specificity and overall lesion detection 
rate of DBT were significantly higher. The addition of mammography CC view to DBT 
improved sensitivity. Results will be discussed and potential scenari for clinical use of breast 
tomosynthesis will be shared with the audience. 
Learning Objectives:
1. To illustrate the results from a clinical performance study comparing digital 
breast tomosynthesis (DBT) with digital mammography (FFDM).
2. To share the vision of possible clinical use of tomosynthesis, based on these 
results.
D-14	  
Routine use of digital tomosynthesis for lung nodule detection: clinical, 
workflow and economic impacts 
S. Kheddache, M. Boijsen, Å.A. Johnsson, A. Svalkvist, S. Zachrisson, A. Flinck, 
L.G. Månsson, M. Båth, J. Vikgren; Gothenburg/SE 
Since December 2006, two pulmonary nodule detection studies, enrolling 114 
consenting patients and more than 4800 chest tomosynthesis examinations 
(TS) (VolumeRad, GE) have been performed at Sahlgrenska University Hospital, 
Göteborg, Sweden. The most frequent indications for TS have been suspicion 
of a nodule, tumour, pneumothorax, cavitation or possible confounding skeletal 
pathology seen on conventional chest radiography (CXR). CXR suffers from low 
sensitivity and specificity. Patients are often referred to computed tomography (CT) 
for further work-up of suspicious findings. CT often solves the problem, but has 
disadvantages such as high radiation dose and high costs. TS offers an improved 
chest radiography method, which can be used to select patients who need further 
investigation with CT, thereby significantly reducing radiation dose to population (at 
least by a factor of 20), optimising the use of CT resources and reducing operat-
ing costs in the department. However, TS showed some limitations, such as the 
requirement for patients to hold their breath for 10s and limited depth resolution of 
reconstructed images. In the clinical setting at our institution, TS is now routinely 
used as an adjunct examination to CXR to decide whether to recommend CT or 
not, based on the findings of the combination of CXR and TS. TS is also used in 
selected cases for follow-up of pathology which has been confirmed by CT. TS 
is currently requested by the referring clinicians in more than 50% of TS cases 
performed. Being part of routine care in our institution, TS is coded and reimbursed. 
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D-15	  
Contrast-enhanced spectral mammography: clinical benefits in diagnostic 
workflow 
C. Dromain; Villejuif/FR 
Purpose: Quantify the additional clinical performance and derive the benefits of con-
trast enhanced spectral mammography (CESM) as an adjunct to standard of care (dig-
ital mammography (MX) and ultrasound (US)) in a diagnostic population of women. 
Materials and Methods: After ethics committee approval 120 consenting patients 
recalled for diagnostic work-up were imaged with MX, US and CESM. CESM exami-
nations were performed using a GE Healthcare (Chalfont St-Giles, UK) Senographe 
DS system, modified for paired dual energy exposures (below and above the K-edge 
of iodine) as well as image recombination for contrast visualization with texture 
cancellation. Intra-venous injection of iodinated contrast agent (300mg/ml) followed 
a standard CT protocol (1.5ml/kg of weight at 3ml/s rate). Truth was checked for 112 
patients with histology, cytology or minimum 1-year follow-up. Seven experienced 
breast radiologists blinded on truth and clinical history performed individual interpre-
tations of MX, US and CESM images. Findings were localized and assessed with BI-
RADS scores (0 not allowed). Areas under the ROC curves (Az), sensitivity and false 
positive fraction were calculated using BIRADS 4 as threshold for positive readings. 
Results: The dataset included a total of 150 proven lesions (86 malignant and 
64 benign). Clinical performance (Az) with CESM increased for each reader 
and overall: areas under the ROC curves across the readers for MX+US and 
MX+US+CESM were 0.83 and 0.88 (p<0.05). Per lesion mean sensitivities for 
malignancies were 65.6% and 71.8% respectively (p<0.05) with a slight increase 
in the false marker rate per image: 0.49 for MX+US and 0.54 for MX+US+CESM. 
Conclusion: Addition of CESM to standard mammography and ultrasound signifi-
cantly increased clinical performance and sensitivity across the readers. CESM 
should play a significant role as a problem solving and staging tool in the breast 
lesion diagnostic workflow. 
12:30 - 13:30 Room E1 
organised by Guerbet
SY 10 
Patient management in oncology: screening, 
diagnosis and staging of colorectal cancer 
Moderator: 
D.-M. Koh; Sutton/UK 
D-16	  
How to improve the patient management in oncology with complementary 
techniques? 
D.-M. Koh; Sutton/UK 
D-17	  
Patient acceptance improvement with minimal bowel preparation in 
screening CT colonography 
J. Stoker; Amsterdam/NL 
CT-colonography is widely used in patients suspected of colorectal cancer. The tech-
nique is already used for screening in some countries and is a (potential) candidate 
for screening in other countries. Extensive bowel preparation is considered as the 
most burdensome part of the CT-colonography examination and therefore limited 
bowel preparation has been introduced. This bowel preparation concerns tagging 
of faecal residue with either iodine or barium, such that full cathartic cleansing is no 
longer mandatory. This limited bowel preparation is combined with a low fibre diet 
for homogenously tagged stool. Colonoscopy cannot be performed at the same day, 
except when additional cleansing is performed. Studies on limited bowel preparation 
have shown that the accuracy is comparable to extensive bowel preparation, while 
the acceptance is better. This is not only important for symptomatic patients but 
also is crucial for screening. Screening techniques are evaluated for their yield and 
cost effectiveness. Yield concerns the detection of important lesions multiplied by 
the attendance. A technique with a good acceptance will lead to a better adherence 
to a screening program and - with comparable accuracy - higher yield. This might 
prove crucial for CT-colonography to be widely accepted as a screening technique. 
D-18	  
Water-coloCT: an alternative imaging technique for colon cancer diagnosis 
P.-J. Valette; Lyon/FR 
CT is essential for the diagnosis of colonic diseases. Its contribution now extends to 
tumour or chronic inflammatory diseases. Two technical approaches are proposed to 
obtain the colonic distension: - air insufflation (in fact CO2), with three-dimensional 
reconstructions to perform a virtual colonoscopy, - water enema. An IV injection 
of iodine is then performed with image acquisition at the venous time. The main 
purpose of the water-coloCT is to reveal the existence of a colonic stenosis and/
or parietal lesions with precise description of the extent and aspect in favor of en-
hancement by iodine. Lymph nodes and metastases are also checked, for staging 
of the tumour. Various studies have demonstrated the excellent sensitivity (98%) 
of the water-coloCT for detection of colonic tumours including small lesions. More 
useful, is its near-perfect negative predictive value (99%). Because of its simplicity, 
water-coloCT finds its ideal indications in symptomatic patients but at risk for a 
real colonoscopy with general anesthesia. The addition of a simple water enema 
during scanners performed for assessment of inaugural liver metastases with un-
known primary tumour makes also possible the immediate detection of the colonic 
origin if so. In practice, water-coloCT is therefore directed to symptomatic patients 
suspected of having colon cancer, and is a complementary technique of virtual 
colonoscopy in the screening of adenomatous polyps in non symptomatic patients. 
D-19	  
Dynamic MR imaging in liver staging after colon cancer 
T.J. Vogl, R. Hammerstingl; Frankfurt a. Main/DE 
Liver metastases are the most common cause for liver malignancy. High precision 
in detecting, localizing, and characterizing lesions in liver staging after colon cancer 
is important, because further treatment decision may have consequences for the 
prognosis of the patient. Improvements in imaging modalities have contributed to 
a better depiction, delineation and classification of tumors. Contrast-enhanced MR 
imaging has become an essential part of liver examination in a number of circum-
stances. Extracellular fluid space contrast agents are safe compounds in handling 
and provide information on vascularization and perfusion of focal liver tumors. A 
dynamic contrast-enhanced study of the liver is performed during the arterial, portal 
venous, and delayed phase of enhancement. Fast spoiled GRE allows thin-section 
imaging of the entire liver during a single breath-hold. New volumetric sequences 
have enabled three-dimensional dynamic imaging with a very high spatial and 
temporal resolution. The key issue of contrast agents in hepatic imaging is to dis-
criminate between tissue that cannot be adequately differentiated on unenhanced 
MR imaging. Different characteristic features of the intravascular and extracellular 
spaces of the various focal liver lesions are depicted by extracellular gadolinium 
contrast agents. Dynamic imaging has also been shown to improve not only the 
distinction of malignant lesions but also to achieve the specific diagnosis for most 
liver tumors and to identify benign disease precisely. Peripheral rim-enhancement, 
wash-out effect, triangle and wedge sign are typical characteristics of metastases. 
D-20	  
Whole-body staging with contrast-enhanced PET-CT 
G. Antoch; Düsseldorf/DE 
Diagnostic potentials - as well as limitations - associated with morphological 
cross-sectional imaging on the one hand, and functional imaging on the other, are 
increasingly well understood. It has become obvious that in many cases both kinds 
of imaging complement one another. Therefore, hybrid PET/CT imaging must be 
considered one of the most important new developments in medical imaging in 
the past decade. When coupling PET with contrast-enhanced CT data whole-body 
staging of colorectal tumours may be accomplished in a single session offering 
both diagnostic CT and diagnostic PET data. However, some questions have to 
be raised and challenges have to be met to avoid overrating PET/CT when staging 
colorectal disease. The accuracy of PET using FDG as a radionuclide is only low 
when assessing the T-stage and N-stage of colorectal tumours. Specified PET/CT 
protocols, such as PET/CT-colonography, may increase this accuracy. However, 
the main indication for PET/CT in colorectal disease has been staging for distant 
metastases. In this setting FDG-PET/CT has been reported of high sensitivity with 
advantages over other imaging procedures. However, even in tumor staging FDG-
PET/CT may have limitations in body regions such as the brain (high physiological 
FDG uptake) or the liver (breathing motion). This talk summarizes the indications 
of contrast-enhanced PET/CT in whole-body staging of colorectal tumors. Potential 
limitations of the imaging procedure will be addressed. 
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D-21	  
Questions and conclusion 
D.-M. Koh; Sutton/UK 
12:30 - 13:30 Room F1 
organised by Hitachi
SY 11 
Hitachi real-time tissue elastography (HI-RTE):  
from the experts 
Moderator: 
D. Musset; Clamart/FR 
D-22	  
Welcome and introduction 
D. Musset; Clamart/FR 
D-23	  
State of the art Hitachi real-time tissue elastography: characterisation of 
focal breast lesions 
A. Thomas, T. Fischer; Berlin/DE 
In the recent years, advanced techniques have revolutionised breast ultrasound 
(US). The new possibilities comprise techniques for optimising image quality 
such as tissue harmonic imaging (THI) and frequency compounding (FC), tools 
for post-processing US raw data such as strain imaging (elastography), and the 
use of real-time tissue elastography. Initial data suggest that elastography can 
improve the specificity of ultrasound in differentiating benign and malignant breast 
lesions. Calculation of strain ratios contributes to the standardisation of real-time 
tissue elastography with a high sensitivity and allows significant differentiation of 
breast lesions with a higher specificity compared to B-mode, subjective evaluation 
of elastography and mammography. The presentation will focus on characteristic 
features of malignant and benign breast lesions using state of the art US techniques 
with a special focus on elastography and calculation of strain ratios. 
Learning Objectives:
1. To learn how to use new US techniques with classification of focal lesions 
according to BI-RADS and Ueno Scores.
2. To learn how to use new US techniques with presentation of examples that 
demonstrate the benefits of elastography.
3. To learn how to use new US techniques with characteristic features of strain 
ratio quantification.
4. To learn how to use new US techniques with outlook: new techniques for 
breast elastography.
D-24	  
New aspects in tendon imaging 
A. Klauser; Innsbruck/AT 
Real-time tissue elastography in tendons: is there any value? Imaging has been 
used as a yardstick for diagnosing tendinopathies and in particular achillodynia, 
with MRI and US as the most commonly used modalities in clinical routine. How-
ever, in the literature, the value of these methods is somewhat controversial when 
compared with clinical assessment. The etiology of tendon disorders is believed to 
be multifactorial. Repetitive microtrauma and vascular alteration as well as hypoxic, 
mucoid, calcifying, and lipoid degenerations may lead to microscopic alterations, 
tendon thickening, partial tearing and subsequent full-thickness ruptures. Clinical 
differentiation between tendinopathy, partial tears, and even paratendinitis may 
be difficult, and therefore imaging is used, predominantly MRI and US. In the 
musculoskeletal field, real-time tissue elastography can help improve estimation 
of tendon stiffness, which might give additional information in the cycle of tendon 
degeneration to conventionally used imaging modalities. The usefulness of elas-
tography can be expected to increase rapidly in the musculoskeletal field, as soon 
as we learn to interpret elastographic artifacts as well as to take advantage of the 
new information provided by real-time tissue elastography. Preliminary findings of 
real-time tissue elastography in healthy and pathological Achilles tendons, technical 
considerations, examination technique and several limitations will be addressed. 
D-25	  
Hitachi real-time tissue elastography in radiology 
P.S. Sidhu; London/UK 
Real-time tissue elastography of the testis - a useful tool? Ultrasound is the 
‘gold-standard’ of imaging of the scrotal sac and is unparalleled in that in almost 
all instances it out-performs other imaging modalities. The development of high-
frequency transducers and exquisitely sensitive colour Doppler methods has revo-
lutionised the assessment of the scrotal contents. Nevertheless, clinical palpation 
remains the cornerstone of diagnosis particularly in the assessment of the testicular 
tumour, deciding whether malignancy is present. Newer technology introduced to 
ultrasound, and in use in other areas of the body, may find an application in the 
scrotal sac. Real-time tissue elastography may scrutinise the lesion within the 
testis, particularly the small indeterminate intra-testicular lesion, and characterize 
the ‘hardness’ aiding management and perhaps avoiding unnecessary surgery or 
orchidectomy. Areas of ischaemic change and scarring, demonstrating different 
elastography patterns from tumour, may be identified with added confidence. Global 
testicular disease causing fibrosis and infertility may present characteristic patterns 
on elastography, avoiding testicular biopsy for confirmation. This presentation will 
demonstrate the various appearances of testicular pathology on real-time tissue 
elastography, indicating areas where this technique may be useful and suggesting 
areas for further research and eventual clinical utility. 
D-26	  
Non-invasive evaluation of liver fibrosis using Hitachi real-time tissue 
elastography 
K. Fujimoto; Tanabe/JP 
Assessment of liver fibrosis stage using the liver fibrosis index (LF Index). Within 
the long-term scenario of chronic hepatitis C, the relationship between the risk of 
hepatocellular carcinoma and the stage of liver fibrosis has been reported. Thus 
histological diagnosis by liver biopsy is important to evaluate the stage of hepatic 
fibrosis; however, it is an invasive technique. Previously, measurement of platelet 
count and liver fibrosis markers have been used as non-invasive tests to evaluate 
liver fibrosis, combined with diagnostic imaging methods such as ultrasonography. 
Recently, real-time tissue elastography (RTE) has been developed. This technique 
has implemented the combined autocorrelation method for the high-speed calcula-
tion and real-time colour display of relative tissue stiffness derived from tissue strain. 
We have examined the accuracy of RTE for the evaluation of liver fibrosis in chronic 
hepatitis C and reported that the liver elasticity score, which was scored visually, 
significantly increased as fibrosis stage progressed and reflected the degree of 
liver fibrosis. We performed RTE on 310 patients with chronic hepatitis C (and/
or liver cirrhosis) and 15 healthy volunteers. Nine image features were extracted 
from each RTE image and a multiple regression analysis was performed to derive 
the regression equation. This equation calculates a liver fibrosis index (LF Index), 
which in turn predicts the fibrosis (F) stage of the liver. LF Index not only correlates 
highly with the F stage (r=0.68), but also it shows significant differences in LF Index 
values (p<0.001) between each stage of fibrosis. As a result, it was possible to as-
sess liver fibrosis stage non-invasively using elastography. The liver fibrosis index 
(LF Index) highly correlated with histological assessment of liver fibrosis stage. 
12:30 - 13:30 Room F2 
organised by Philips Healthcare
SY 12 
Programme not available by date of print 
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12:30 - 13:30 Room G/H 
organised by Philips Healthcare
SY 13 
Advances in radiology ultrasound using iU22 
xMATRIX technology 
Moderator: 
E. Danse; Brussels/BE 
D-27	  
Liver and renal 3D conventional and contrast-enhanced US using the iU22 
xMatrix system: technical innovation or clinical revolution 
J.-M. Correas; Paris/FR 
D-28	  
xMatrix ultrasound: the power of CT/MR in your hand 
S.T. Elliott; Newcastle upon Tyne/UK 
12:30 - 13:30 Room I/K 
jointly organised by Bracco and Toshiba
SY 14 
Contrast enhanced ultrasound (CEUS): 
the effective imaging solution 
Moderator: 
M. Claudon; Vandoeuvre-lès-Nancy/FR 
D-29	  
New clinical data to support DCE-US as the imaging modality for the 
monitoring of anti-angiogenesis therapies efficacy 
N. Lassau; Villejuif/FR 
The early functional evaluation of new treatments is a main goal. At present, tech-
nical advances in DCE-ultrasonography using bolus contrast agent (SonoVue®, 
Bracco) and perfusion software allow the detection of micro-vascularisation and 
perfusion of superficial and deep malignant tumours. Thus, it becomes possible to 
early evaluate the efficiency of antiangiogenic or anti-vascular molecules. Treatment 
response can be early predicted according to modifications of this vascularisation 
before any volume modification. The acquisition of raw linear data affords the precise 
quantification (peak intensity, time to peak intensity, slope of wash-in, and area 
under the curve, etc.) of the perfusion after contrast uptake curves modelisation, 
particularly using time tracking of region of interest. The results obtained in our 
institution on 117 patients, will be focused on GIST, RCC, HCC, and melanoma 
treated with different molecules. Reduction in tumour vascularisation can easily be 
detected in responders after 1 or 2 weeks and is correlated with progression-free 
survival and overall survival in RCC or HCC. DCE-US is supported by the French 
National Cancer Institute (INCa), which is currently studying the technique in meta-
static breast cancer, melanoma, colon cancer, gastrointestinal stromal tumours and 
renal cell carcinoma, as well as in primary hepatocellular carcinoma, to establish 
the optimal perfusion parameters and timing for quantitative anticancer efficacy as-
sessments. Final results: 539 patients evaluated in 19 centers with more than 2000 
DCE-US demonstrating that AUC could be a robust parameter to predict response. 
D-30	  
Evaluation of the clinical impact of CEUS in the treatment of abdominal 
aneurysm 
V. Cantisani; Rome/IT 
Endovascular aneurysm repair (EVAR) is an effective alternative treatment to open 
repair of abdominal aortic aneurysm and the number of EVAR procedures carried 
out worldwide is continuously growing. Incomplete exclusion of the aneurysm sac 
from the circulation, defined as endoleak, is the most frequent complication after 
EVAR occurring in 10% to 45% of cases, and it can be associated with aneurysm 
enlargement and possibly rupture. Despite its notable advantages, ultrasonography 
has not yet achieved reference standard status in the EVAR follow-up because of 
low diagnostic specificity and sensitivity. Recent studies on ultrasound examinations 
performed without echo-contrast agents reported sensitivity rates ranging from 43% 
to 97%, such wide differences suggesting that it does not guarantee the neces-
sary reliability (4,5). Therefore, to date computed tomography angiography (CTA) 
is the preferred imaging modality to follow-up patients after EVAR. However, CTA 
surveillance carries the risks associated with radiation and contrast media exposure. 
Magnetic resonance angiography (MRA) and contrast-enhanced ultrasonography 
(CEUS) have been shown in some studies a better accuracy than CTA (6, 7-13). 
However, there is no consensus with regard of optimal work-up with diagnostic 
imaging modalities in surveillance after EVAR. The accuracy of current imaging 
modalities in the detection and characterisation of endoleaks in aortic endografts, 
focusing especially on the accuracy of CEUS with the use of second generation 
contrast agent have been presented. The advantages, the limitations of CEUS in 
comparison with CTA and MRA, will be discussed. 
D-31	  
The role of CEUS in the assessment of renal graft: immediate and long 
term transplant follow-up 
T. Fischer; Berlin/DE 
Contrast ultrasound is a promising and new method that is superior to established 
ultrasound techniques like conventional B-mode scanning for volume measurement, 
demonstration of hematoma and colour Doppler for the detection of acute rejection 
or perfusion defects in the diagnostic evaluation of kidney grafts. Moreover, contrast 
enhanced ultrasound has the potential for tumour characterisation in transplant 
and normal kidneys. A single examination by contrast ultrasound can answer a 
variety of questions in the early postoperative phase and long-term follow-up. Initial 
studies show that efficient and early diagnosis of rejection or acute tubular necrosis 
(ATN) is possible as these conditions have characteristic bolus kinetics. Surgical 
complications like perfusion defects secondary to thrombosis of a polar artery or 
postoperative hematoma are also identified. Perfusion effects of an hematoma can 
also be assessed in standardised manner. 
14:00 - 15:30 Room C 
organised by Hologic
SY 15 
The use of breast tomosynthesis in clinical practice 
Moderator: 
A. Smith; Bedford, MA/US 
Programme not available by date of print 
14:00 - 15:30 Room E1 
organised by Siemens
SY 16 
Shaping the future of molecular and magnetic 
resonance imaging 
Moderator: 
M. Schwaiger; Munich/DE 
D-32	  
Reducing CT dose in myocardial perfusion SPECT/CT 
E. O’Shaughnessy; Poole/UK 
Aims: To reduce the CT dose for attenuation correction to SPECT 
studies as much as possible without adversely affecting its accuracy. 
Methods: Using the Perspex CTDI phantom with the Xi detector to measure 
dose, CT scans were acquired using the Siemens Symbia T over the range of 
CareDOSE settings. Using the default setting ‘ACEmean’ the measured dose at 
the centre of the phantom was 1.675mGy and the breast dose from the topogram 
was 0.3mGy. The lowest dose was achieved using the setting ‘DOM’ where the 
doses were reduced to 1.205mGy and undetectable respectively. To observe the 
effect of changing these settings, 30 patients received a stress scan with default 
CT settings and a rest scan utilising SPECT guided CT and the new settings. 
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Results: The mean dose reduction for 30 patients was 23.5%. The dose reduction 
was greatest for larger patients. The largest dose reduction for one patient was 
2.5mSv for ‘ACEmean’ settings to 0.7mSv for ‘DOM’ settings. There was no appar-
ent difference in attenuation correction between the two sets of resultant images. 
Conclusion: The average CT dose was reduced by 23.5% over the 30 patients 
studied. These new low-dose settings have now been applied to all clinical studies. 
Learning Objectives:
1. To appreciate the range of CT doses resulting from the default low-dose 
CareDOSE settings.
2. To learn how these CT doses have been reduced in nuclear medicine at 
Poole Hospital NHS Foundation Trust.
3. To appreciate the dose reduction achieved.
D-33	  
Whole-body MR-PET: first experiences 
M. Schwaiger; Munich/DE 
D-34	  
Clinical relevance and potential of 3 Tesla for musculoskeletal imaging: 
first experiences using MAGNETOM Skyra 
T.C. Mamisch; Berne/CH 
Aims: Improvement of clinical diagnostic performance and worklflow 
us ing  3T MRI  w i th  ded ica ted  musku lo -ske le ta l  imag ing  co i l s . 
Methods: Overview of current approaches in musculo-skeletal imaging at 3T 
from clinical protocols routinely used to new research work. The presentation 
will focus on improvements in diagnostic imaging for indication, planning and 
follow up of therapy. Follow areas will be covered:1. High Resolution Fast imag-
ing: Enabling better SNR at 3T and using dedicated coils to deliver extremely 
high resolution within clinically acceptable examination times. Alternative for 
customers who require increased throughput the scan time can be drastically 
reduced using 3T. 2. 3D Isotropic Imaging as a means of delivered enhanced 
workflow and increased quality of diagnosis. 3. Biochemical Imaging for improved 
diagnostical capability and therapy planning. 4. Orthopedic dedicated coils to 
fully capitalise on the benefits of 3T and to open up new areas of study not 
previously possible i.e. biochemical imaging of the cartilage in the wrist or ankle. 
Conclusion: 3T MRI using dedicated coils advances MR imaging of the musculo-
skeltal system. This supports development of new therapy concepts, i.e. drugs, 
cartilage repair, stem cells and preserving surgery, as the advances in musculo-
skeletal imaging are capable of grading and staging of the diseases for precise 
diagnosis and monitoring of therapy. 
Learning Objectives:
1. To summarise current literature and own experiences of clinical use and 
relevance of 3T MRI in muskulo-skeletal imaging.
2. To learn about clinical advantages to use 3T MRI.
3. To learn about optimisation of protocols at 3T.
4. To give an overview on new application on 3T, as 3D isotropic - or functional 
imaging.
5. To learn more intial experiences and potential improvements of 
musculoskeletal imaging using dedicated 16 channel coils at MAGENTOM 
Skyra.
14:00 - 15:30 Room F2 
organised by GE Healthcare
SY 17 
Promise of advanced oncology imaging 
Moderator: 
R.C. Sigal; Velizy/FR 
D-35	  
Latest guidance technologies for interventional oncology 
F. Deschamps; Villejuif/FR 
Interventional radiologists need 3D information to plan and guide percutaneous or 
vascular procedures. The Innova (=trademark of General Electric Company) Vision, 
the Innova TrackVision and FlightPlan for Liver applications from GE Healthcare 
provide great help for real-time guidance. The Innova Vision application is used for 
better understanding of the 3D anatomy and for real time guidance of the catheter 
during vascular procedure by providing a virtual “3D road-map” which superim-
poses the live fluoroscopic images with Innova 3D reconstruction. 3D models, 
such as hepatic arteries or portal veins, can be reconstructed from subtracted 
or non-subtracted Innova 3D rotational angiography, computed tomography or 
magnetic resonance images. This 3D road-map is automatically adjusted in real 
time for all changes in C-arm angulations, field of view and table positions. The 
Innova TrackVision application is used to plan and guide needle trajectories for 
percutaneous procedures such as biopsy, cementoplasty or radiofrequency abla-
tion. After performing an Innova 3D acquisition, the user defines the entry and 
target points on the Advantage Workstation Volume Share. The line between these 
two points is automatically superimposed on the fluoroscopic image as a “virtual 
needle”. The “bull’s eye” view, which shows the virtual needle as a single point, 
increases confidence in the optimal needle position for skin entry and in the right 
direction for progression. The “progress view”, which shows the needle trajectory 
as a line, monitors the advancement of the needle to the target. The FlightPlan 
for Liver is the ultimate dedicated oncology guidance tool which automates the 
selection of the arterial path from the main arterial entry to the selected target in 
the liver and displays the color coded vessel path to help speed up endovascular 
liver interventional procedures significantly. This improves the physicians ability to 
determine tumour feeding vessels. When combining the FlightPlan for Liver with 
Innova Vision, the 3D path can be directly superimposed on fluoroscopy and can 
help to perform interventions more quickly and with more confidence. 
D-36	  
MR guided focused ultrasound (MRgFUS) for treating oncology patients 
C. Catalano, A. Napoli; Rome/IT 
MR guided focused ultrasound surgery (ExAblate, InSightec Ltd) is a completely 
non-invasive method of thermally ablating target tissue, while preserving sur-
rounding tissues and organs. The combination of MR guidance with high intensity 
ultrasound waves enables planning and continuous real time guidance with a high 
safety profile, providing personalize treatment which is adjusted to the individual 
patient. MRgFUS is becoming an established treatment option for uterine fibroids 
and increasing data is being developed for use in various oncology applications. 
We report on the results in our center for pain palliation of bone metastases and 
other bone tumours, pancreas, and other indications. 
D-37	  
The role of fusion imaging in complex biopsy and ablative procedures 
J.-M. Correas; Paris/FR 
The purpose of this presentation is to report our preliminary experience with the 
LOGIQ E9 V Nav - Fusion Imaging feature for performing complex biopsy and 
ablative procedures. Fusion Imaging in Ultrasound refers to the possibility to fuse 
live ultrasound acquisition with pre-acquired DICOM volume dataset obtained from 
other imaging modalities such as MRI, CT and PET-CT. This technique is taking 
advantage of the specific value of each imaging modality, as the temporal resolution 
and easy of use of ultrasound to the higher spatial and contrast resolution of CT and 
MRI. This leads to additional clinical information that helps to increase his confidence 
in performing difficult procedures. In addition to Fusion Imaging, additional features 
of the V Nav Package were evaluated. The GPS markers keep tracking the position 
of marked anatomical structures or references while scanning, enabling an easier 
access to difficult to reach lesion or simply helping to mark a poorly visible lesion 
at Ultrasound while visible in CT/MRI before treatment. The possibility to combine 
GPS, Contrast Enhanced Ultrasound and Fusion Imaging (US/US), together with 
the Automatic Ultrasound to Ultrasound registration, increased further the clinical 
confidence in the pre-interventional and interventional phases performed under 
Ultrasound guidance. The Needle Tracking, a reusable V Nav sensor embedded 
in the tip of a needle, enables interventional procedures to be planned using any 
needle insertion path, including an approach that is out of plane with the ultrasound 
image. As the needle is inserted, the needle path and trajectory are projected onto 
the current image. Because the sensor is at the distal tip of the needle, the tip and 
trajectory graphics are correct even when the needle bends. 
14:00 - 15:30 Room N/O 
organised by Sectra
SY 18 
Programme not available by date of print 
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Sunday, March 6
12:30 - 13:30 Room C 
organised by GE Healthcare
SY 19 
Redefining the rules of CT imaging: 
new frontiers for patient care and image quality 
Moderator: 
A. Laghi; Latina/IT 
D-38	  
New insights from contrast media research 
J.A. Jakobsen; Oslo/NO 
D-39	  
Gemstone spectral imaging (GSI): a significant advance in the diagnostic 
performance of CT for emergency imaging? 
J. de Mey; Brussels/BE 
D-40	  
Ultra low dose abdominal CT with iterative reconstruction technologies: 
how low can you go? 
M.M. Maher; Cork/IE 
12:30 - 13:30 Room G/H 
organised by Philips Healthcare
SY 20 
Programme not available by date of print 
12:30 - 13:30 Room I/K 
organised by Bracco
SY 21 
Programme not available by date of print 
12:30 - 13:30 Room L/M 
organised by Siemens
SY 22 
Pioneering innovations in ultrasound 
D-41	  
Acoustic radiation force imaging (ARFI): repeatability of measurements 
and assessment in relation to immediate targeted liver biopsy 
P.S. Sidhu; London/UK 
Acoustic radiation force imaging (ARFI) is a promising non-invasive technique in 
the assessment of liver fibrosis with the ultimate aim being to avoid or at least delay 
liver biopsy in patients with chronic liver disease. With any technique, the ability to 
reproduce accurate measurements is paramount to the success of the technique 
in the clinical scenario. Furthermore the measurements should be reproducible be-
tween different operators using the technology. Reproducibility studies are essential 
to the clinical utility of this new technique and recent studies have confirmed the 
robustness in clinical imaging. A further limitation of any non-invasive technique is 
the patchy nature of the distribution of fibrosis in the diseased liver, a problem also 
encountered with targeted biopsy. If the results of an ARFI measurement are to have 
credibility, the ‘reference’ standard has to be the ultimate of histology from the exact 
site sampled by the ARFI ‘region-of-interest’ box. To this effect a series of patients 
being investigated for the possibility of fibrosis underwent ARFI followed immediate 
biopsy from the same site. Both reproducibility studies and results from targeted 
biopsy will be presented to give an overview of the robustness of the technique. 
D-42	  
Strain imaging and automated ultrasound in the breast 
C.S. Balleyguier; Villejuif/FR 
D-43	  
Automated image fusion: a new processing approach in clinical use 
D.-A. Clevert; Munich/DE
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